Loading people...
Matthew Foy is a biotech entrepreneur and life sciences investor based in London, United Kingdom. He holds a Bachelor of Science and a Master of Science in Biological Sciences, with a specific concentration in Cell and Molecular Biology, from the University of Oxford. To integrate his scientific expertise with commercial applications, he completed specialized academic programs in Drug Discovery at University College London and studied Entrepreneurship and Strategy at London Business School. Operating within the early-stage startup ecosystem, his professional work centers on bridging complex academic research with viable business models to accelerate the development of novel medical treatments. Foy evaluates emerging technologies and provides strategic guidance to life sciences companies navigating the commercialization process. His background combines rigorous molecular biology training with business strategy to focus on advancing innovative therapies and drug discovery ventures.
Matthew Foy is Partner at SR One.